Article PDF
References
Michaelson IC . The mode of development of the vascular system of the retina, with some observations for its significance for certain retinal diseases. Trans Ophthalmol Soc UK 1948; 68: 137–80.
Ashton N . Arteriolar involvement in diabetic retinopathy. Br J Ophthalmol 1953; 37: 282–92.
Ashton N . Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmol 1963; 47: 521–38.
Ashton N . Retinal vascularisation in health and disease. Am J Ophthalmol 1957; 44: 7–20.
Archer DB, Ernest JT, Newell FW . Classification of branch retinal vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 148–65.
Shilling JS, Kohner EM . New vessel formation in retinal branch vein occlusion. Br J Ophthalmol 1976; 60: 810–15.
Kohner EM, Shilling JS, Hamilton AM . The role of avascular retina in new vessel formation. Metab Ophthalmol 1976; 1: 15–23.
Shimizu K, Kobayashi Y, Muraoka K . Midperipheral fundus involvement in diabetic retinopathy. Ophthalmol 1981; 88: 601–12.
Wise GN . Retinal neovascularisation. Trans Am Acad Ophthalmol Otolaryngol 1956; 54: 729–826.
Patz A . Clinical and experimental studies on retinal neovascularisation. Am J Ophthalmol 1982; 94: 715–43.
Henkind P . Ocular neovascularisation. Am J Ophthalmol 1978; 85: 287–301.
Neupert JR, Brubaker RF, Kearns TP, Sundt TH . Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 1976; 81: 600–2.
McLeod D . Reappraisal of the retinal cotton-wool spot: a discussion paper. J Roy Soc Med 1981; 74: 682–6.
Archer DB . Retinal neovascularisation. Trans Ophthalmol Soc UK 1983; 103: 2–27.
Finkelstein D, Clarkson J, Diddie K, Hillis A, Kimball A, Orth D, Trempe C . Branch vein occlusion: retinal neovascularisation outside the involved segment. Ophthalmol 1982; 89: 1357–61.
Magargal LE, Brown GC, Augsburger JA, Parrish R . Neovascular glaucoma following central retinal vein obstruction. Ophthalmol 1981; 88: 1095–101.
Forrester JV, Wilkinson PC . Inhibition of leucocyte locomotion by hyaluronic acid. J Cell Sci 1981; 48: 315–31.
Garner A . Ocular angiogenesis. Int Rev Exp Pathol 1986; 28: 249–306.
Mandelcorn MS, Blankenship G, Machemer R . Pars plana vitrectomy for the management of severe diabetic retinopathy. Am J Ophthalmol 1976; 81: 561–70.
Michels RG . Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol 1978; 96: 237–46.
Charles S . Vitreous Microsurgery, 2nd ed. Baltimore, London, Williams & Wilkins, 1987.
Rice TA, Michels RG, Maguire MG, Rice EF . The effect of lensectomy on the incidence of iris neovascularisation and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1983; 95: 1–11.
Trempe CL, Takahashi M, Topilow HW . Vitreous changes in retinal branch vein occlusion. Ophthalmol 1981; 88: 681–7.
Wong HC, Sehmi KS, McLeod D . Abortive neovascular outgrowths discovered during vitrectomy for diabetic vitreous haemorrhage. (In press).
Chan CC, Little HL . Infrequency of retinal neovascularisation following central retinal vein occlusion. Ophthalmol 1979; 86: 256–62.
Ashton N, Cook C . Studies of developing retinal vessels. I. Influence of retinal detachment. Br J Ophthalmol 1955; 39: 449–56.
McLeod D . Silicone oil injection during closed microsurgery for diabetic retinal detachment. Graefes Arch Klin Exp Ophthalmol 1986; 224: 55–9.
Yeo JH, Glaser BM, Michels RG . Silicone oil in the treatment of complicated retinal detachments. Ophthalmol 1987; 94: 1109–13.
McLeod D, James CRH . Viscode lamination at the vitreoretinal juncture in severe diabetic eye disease. Br J Ophthalmol 1988; 72: 413–19.
Hercules BL, Gayed II, Lucas SB, Jeacock J . Peripheral retinal ablation in the treatment of diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. Br J Ophthalmol 1977; 61: 555–63.
Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of DRS findings. Ophthalmol 1981; 88: 583–600.
Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion. Arch Ophthalmol 1986; 104: 34–41.
May DR, Klein ML, Peyman GA, Raichand M . Xenon-arc panretinal photocoagulation for central retinal vein occlusion: a randomised prospective study. Br J Ophthalmol 1979; 63: 725–34.
Ficker LA, Passani F, Leaver PK, McLeod D . Xenon-arc endophotocoagulation during vitrectimy for diabetic vitreous haemorrhage. Graefes Arch Klin Exp Ophthalmol 1986; 224: 423–7.
Wolbarsht ML, Landers MB . The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model. Ophthal Surg 1980; 11: 235–45.
Foulds WS . The role of photocoagulation in the treatment of retinal disease. Trans Ophthalmol Soc NZ 1980; 32: 82.
Glaser BM, Campochiaro PA, Davis JL, Jerdan JA . Retinal pigment epithelial cells release inhibitors of neovascularisation. Ophthalmol 1987; 94: 780–4.
Boulton M, Lane C, Singh A, Wong HC, Bridgman A, McLeod D, Marshall J . Effects of vitreous from photocoagulated eyes on retinal microvascular cells in culture: a preliminary report. Curr Eye Res 1988; 7: 465–70.
Cliff WJ . Observations on healing tissue: a combined light and electron microscopic investigation. Philos Trans R Soc 1963; 246: 305–25.
Klintworth GK . The hamster cheek pouch: an experimental model of corneal vascularisation. Am J Pathol 1973; 73: 691–710.
Ishibashi T, Miller H, Orr G, Sorgente N, Ryan SJ . Morphologic observations on experimental subretinal neovascularisation in the monkey. Invest Ophthalmol Vis Sci 1987; 28: 1116–30.
Rifkin DB, Gross JL, Moscatelli D, Jaffe E . Proteases and angiogenesis: production of plasminogen activator and collagenase by endothelial cells. In Nossel HL, Vogel HJ eds. ‘Pathobiology of the endothelial cell’ New York: Academic Press 1982: 191–97.
Weiss JB, Hill CR, Davis RJ, McLaughlin B, Sedowofia KA, Brown RA . Activation of procollagenase by low molecular angiogenesis factor. Biosci Rep 1983; 3: 171–7.
Hill CR, Kissun RD, Weiss JB, Garner A . Angiogenic factor in vitreous from diabetic retinopathy. Experientia 1983; 39: 583–5.
Weiss JB, Brown RA, Kumar S, Phillips P . Tumour angiogenesis factor: a potent low molecular weight compound. Br J Cancer 1979; 40: 493–6.
Weiss JB, Hill CR, Schor A . Low-molecular-mass tumour angiogenesis factor. Biochem Soc Trans 1984; 12: 260.
Kalebic T, Garbisa S, Glaser B, Liotta LA . Basement membrane collagen: degradation by migrating endothelial cells. Science 1983; 221: 281–3.
Ausprunk DH, Folkman J . Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc Res 1977; 14: 53–65.
Folkman J, Haudenschild C . Angiogenesis in vitro. Nature 1980; 228: 551–6.
Glaser BM, Kuwashima L, Sato M, Adler R . The formation and maintenance of new blood vessels. In BenEzra D, Ryan SJ, Glaser BM, Murphy RP, eds. ‘Ocular Circulation’. Dordrecht: Martinus Nijhoff/W. Junk 1987: 77–83.
Ishibashi T, Miller H, Orr G, Sorgente N, Ryan SJ . Mechanisms of lumen formation: morphologic observations on experimental subretinal neovascularisation. In BenEzra D, Ryan SJ, Glaser BM, Murphy RP, eds. ‘Ocular Circulation’. Dordrecht: Martinus Nijhoff/W Junk 1987: 437–443.
Frank RN, Mancini MA . Presumed retinovitreal neovascularisation in dystrophic retinas of spontaneously hypertensive rats. Invest Ophthalmol Vis Sci 1986; 27: 346–55.
Glaser BM . Future trends and concepts. In BenEzra D, Ryan SJ, Glaser BM, Murphy RP. eds ‘Ocular Circulation and Neovascularization’ Dordrecht: Martinus Nijhoff/W. Junk 1987: 565–567.
Kohno T, Sorgente N, Goodnight R, Ryan SJ . Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci 1987; 28: 515–21.
Ashton N . Diabetic micro-angiopathy. Adv Ophthalmol 1958; 8 (bibl Ophthalmol Fasc 52): 1–84.
Garner A . Retinal angiogenesis: mechanism in health and disease. Semin Ophthalmol 1987; 2: 71–80.
Hamilton AM, Marshall J, Kohner EM, Bowbyes JA . Retinal new vessel formation following experimental venous occlusion. Exp Eye Res 1975; 20: 493–7.
Ashton N, Ward B, Serpell G . Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 1954; 38: 397–432.
Ashton N . Oxygen and the growth and development of retinal vessels: in vivo and in vitro studies. Am J Ophthalmol 1966; 62: 412–35.
Foos RY, Kopelow SM . Development of retinal vasculature in perinatal infants. Surv Ophthalmol 1973; 18: 117–27.
Kushner BJ, Essner D, Cohen II, Flynn JT . Retrolental fibroplasia: pathologic correlation. Arch Ophthalmol 1977; 95: 29–38.
Serpell G . Polysaccharide granules in association with developing retinal vessels and with RLE Br J Ophthalmol 1854; 38: 460–71.
Ashton N . Retinal angiogenesis in the human embryo. Br Med Bull 1970; 26: 103–6.
Flower RW, McLeod DS, Lutty GA, Goldberg B, Wajer SD . Postnatal retinal vascular development of the puppy. Invest Ophthalmol Vis Sci 1985; 26: 957–68.
Cogan DG, Kuwabara T . Accessory cells in vessels of the paranatal human retina. Arch Ophthalmol 1986; 104: 747–52.
Nork TM, Wallow IHL, Kramer SJ, Anderson G . Muller cell involvement in proliferative diabetic retinopathy. Arch Ophthalmol 1987; 105: 1424–9.
Foos RY . Acute retrolental fibroplasia. Albrecht Graefes Arch Ophthalmol 1975; 195: 87–100.
Kretzer FL, Hittner HM . Initiating events in the development of retinopathy of prematurity. In Silverman WA, Flynn JT eds. ‘Contemporary Issues in Fetal and Neonatal Medicine: 2. Retinopathy of Prematurity’. Boston, Oxford: Blackwell 1986: 121–152.
Elstow SF, Schor AM, Weiss JB . Bovine retinal angiogenesis factor is a small molecule (molecular mass <600). Invest Ophthalmol Vis Sd 1985; 26: 74–9.
Montesano R, Orci L, Vassalli P . In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 1983; 97: 1648–52.
Frank RN . Basement membranes and retinal neovascularization. In Ben Ezra D, Ryan SJ, Glaser BM, Murphy RP, eds ‘Ocular Circulation and Neovascularization’. Dordrecht: Martinus Nijhoff/W. Junk 1987: 393–400.
Kennedy A, Mancini MA, Frank RN . A type 1 collagen substrate stimulates cultured retinal cells to produce insoluble proteoglycan. Invest Ophthalmol Vis Sci 1986; 27 (Suppl): 327.
Jerdan JA, Glaser BM . The extracellular matrix of the human retinal vasculature. Invest Ophthalmol Vis Sci 1984; 25 (Suppl): 247.
Miller H, Miller B, Zonis S, Nir I . Diabetic neovascularization; permeability and ultrastructure. Invest Ophthalmol Vis Sci 1984; 25: 1338–42.
Juan E de, Wilson D, Hatchell D . Breakdown of the blood-retinal barrier in a model of retinal neovascularization. Invest Ophthalmol Vis Sci 1987; 28: 1108–15.
Taniguchi Y . Ultrastructure of newly formed blood vessels in diabetic retinopathy. J ap J Ophthalmol 1976; 20: 19–28.
Wallow IHL, Geldner PS . Endothelial fenestrae in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1980; 19: 1176–83.
Korte GE, Bellhorn RW, Burns MS . Urethane induced rat retinopathy: plasticity of the blood-retinal barrier in disease. Invest Ophthalmol Vis Sci. 1986; 25: 1027–34.
Grindle CFJ, Marshall J . Aging changes i n Bruch's membrane and their functional implications. Trans Ophthalmol Soc UK 1978; 98: 172–5.
Williams JM, Juan E de, Machemer R . Ultrastructural characteristics of new vessels in proliferative diabetic retinopathy. Am J Ophthalmol 1988; 105: 491–5.
Janzer RC, Raff MC . Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987; 325: 253–7.
Constable IJ . Pathology of vitreous membranes and the effect of haemorrhage and new vessels on the vitreous. Trans Ophthalmol Soc UK 1975; 95: 382–6.
Ausprunk DH, Falterman K, Folkman J . The sequence of events in the regression of corneal capillaries. Lab Invest 1978; 38: 284–94.
Nagpal KC, Patrianokos D, Asdourian GK, Goldberg MF, Rabb MF, Jampol L . Spontaneous regression (autoinfarction) of proliferative sickle retinopathy. Am J Ophthalmol 1975; 80: 885–92.
Klintworth GK, Burger PC . Neovascularisation of the cornea: current concepts of its pathogenesis. Int Ophthalmol Clin. 1983; 23: 27–33.
BenEzra D, Hemo I, Maftzir G . The rabbit cornea — a model for the study of angiogenic factors. In Ocular Circulation and Neovascularisation (Ed BenEzra D, Ryan SJ, Glaser BM, Murphy RP), 1987; Martinus Nijhoff/Dr W Junk Publishers, pp 335–340.
Hudlicka O, Tyler KR . Angiogenesis: The growth of the vascular system. Academic Press 1986.
Zetter BR : The endothelial cells of large and small vessels. Diabetes. 1981; 30: 24–8.
Auerbach R, Kaminska G, Weber J, Gumkowski F, Kaminski M, Morrissey LW, Bielich J, Woods V, Lu WC, Kubai L . Heterogeneity of vascular endothelial cells: its possible role in selective neovascularisation in the eye. In Ocular Circulation and Neovascularisation (Ed BenEzra D, Ryan SJ, Glaser BM, Murphy RP), 1987; Martinus Nijhoff/Dr W Junk Publishers, pp 361–365.
Folkman J, Merler E, Abernathy C, Williams C . Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971; 133: 275–88.
Taylor CM, Weiss JB, Kissun RD, Garner A . Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina. Br J Ophthalmol. 1986; 70: 162–5.
Schor AM, Schor SL, Weiss JB, Brown RA, Kumar S, Phillips P . Stimulation by a low-molecular weight angiogenic factor of capillary endothelial cells in culture. Br J Cancer 1980; 41: 790–9.
Schor AM, Schor SL, Kumar S . Importance of a collagen substratum for the stimulation of capillary endothelial cell stimulation by tumour angiogenesis factor. Int J Cancer 1979; 24: 225–34.
Boulton M, Wong HC, Clark P, Marshall J . A mitogenic factor or factors produced by cultured human retinal pigment epithelial cells. In Ocular Circulation and Neovascularisation (Ed BenEzra D, Ryan SJ, Glaser BM, Murphy RP), 1987; Martinus Nijhoff/Dr W Junk Publishers, pp 529–534.
Morse LS, Sidikaro Y, Terrell J . Retinal pigment epithelium promotes proliferation of choroidal vessels in vitro. Invest Ophthalmol Vis Sci 1986; 27 (Suppl): 327.
Orlidge A, D'Amore P . Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Celt Biol 1987; 105: 1455–62.
Glaser BM, Campochiaro PA, Davis JL, Sato M . Retinal pigment epithelial cells release an inhibitor of neovascularisation. Arch Ophthalmol 1985; 103: 1870–5.
Schweigerer L, Malerstein B, Neufeld G, Gospodarowicz D . Basic fibroblast growth factor is synthesised in cultured retinal pigment epithelial cells. Biochem. Biophys. Res. Comm. 1987; 143: 934–42.
Glaser BM, D'Amore PA, Michels RG, Patz A, Fenselau A . Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol 1980; 84: 298–30.
Wong HC, Boulton ME, Clark P, Bayly M, Marshall J . Retinal pigment epithelial cells produce mitogenic factors for retinal microvascular cells in culture: A preliminary report. Eye 1987; 1: 754–6.
D'Amore P, Klagsbrun M . Endothelial cell mitogens derived from retina and hypothalmus: biochemical and biological similarities. J Cell Biol 1984; 99: 1545–9.
Baird A, Esch F, Gospodarowicz D, Guillemin R . Retina- and eye-derived endothelial cell growth factor: partial molecular characterisation and identity with acidic and basic growth factors. Biochem. 1985; 24: 7855–60.
Hanneken A, McLeod DS, Lutty G, Hjelmeland LM : Non-coincident localization of acidic and basic FGF in fetal bovine retina. Invest Ophthalmol Vis Sci 1987; 28 (Suppl): 259.
Hanneken A, Lutty G, Hjelmeland LM . Localization of basic FGF in normal and diabetic human retinas. Invest Ophthalmol Vis Sci 1988; 29 (Suppl): 182.
Burke JM, Foster SJ . Induction of DNA synthesis by co-culture of retinal glia and pigment epithelium. Invest Ophthalmol Vis Sci 1985; 26: 636–42.
Wong HC, Boulton M, Marshall J, Clark P . Growth of retinal capillary endothelia using pericyte conditioned medium. Invest Ophthalmol Vis Sci 1987; 28: 1767–75.
McIntosh LC, Muckersie L, Forrester JV . Retinal capillary endothelial cells prefer different substrates for growth and migration. Tissue Cell 1988; 20: 193–209.
Gospodarowicz D, Vlodavsky I, Savion N . The extracellular matrix and the control of proliferation of vascular endothelial and vascular smooth muscle cells. J Supramol Struct 1982; 13: 339–72.
Brem S, Preis I, Langer R, Brem H, Folkman J, Patz A . Inhibition of neovascularisation by an extract derived from vitreous. Am J Ophthalmol 1977; 84: 323–8.
Jacobson B, Basu PK, Hasany SM . Vascular endothelial cell growth inhibitor of normal pathologic vitreous. Arch Ophthalmol 1984; 102: 1543–5.
Lutty GA, Thompson DC, Gallup JY, Mello PJ, Patz A, Fenselau A . Vitreous: An inhibitor of retinal extract induced neovascularisation. Invest Ophthalmol Vis Sci 1983; 23: 52–6.
Lutty GA, Mello R, Chandler C, Fait C, Bennett A, Patz A . Regulation of cell growth by vitreous humour. J Cell Sci 1985; 76: 53–65.
Chen C-H, Chen SC . Angiogenic activity of the vitreous and retinal extract. Invest Ophthalmol Vis Sci 1980; 19: 596–602.
Balazs EA, Denlinger JL . The vitreous. In The Eye (Ed Davson H) 1984; Academic Press, pp 533–590.
Lutty GA, Chandler C, Bennett A, Fait C, Patz A . Presence of endothelial cell growth factor activity in normal and diabetic eyes. Curr Eye Res 1986; 5: 9–17.
Baird A, Coller F, Jones K, Guillemin R . Angiogenic fector in human ocular fluids. Lancet 1985; ii 563.
Connor T, Roberts A, Sporn M, Davis J, Glaser B . RPE cells synthesise and release transforming growth factor-beta, a modulator of endothelial cell growth. Invest Ophthalmol Vis Sci 1988; 29 (Suppl): 307.
Wong HC, Boulton M, McLeod D, Bayly M, Clark P, Marshall J . Retinal pigment epithelial cells in culture produce retinal vascular mitogens. Arch Ophthalmol 1988; (in press).
Glaser BM . Extracellular modulating factors and the control of intraocular neovascularisation: an overview. Arch Ophthalmol 1988; 106: 603–7.
Petty RG, Pearson JD, Morgan DM, Mahler RF . Stimulation of endothelial cell growth by sera from diabetic patients with retinopathy. Lancet 1988; i: 208–11.
Sporn MB, Roberts AB, Peptide growth factor are multifunctional. Nature 1988; 332: 217–19.
Glaser BM, Hayashi H, Krause WG . A protease inhibitor accumulates within the vitreous following pan retinal photocoagulation (PRP) in primates: possible mechanisms for the effect of PRP on retinal neovascularisation. Invest Ophthalmol Vis Sci 1988; 29 (Suppl): 180.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boulton, M., McLeod, D. & Garner, A. Vasoproliferative retinopathies: Clinical, morphogenetic and modulatory aspects. Eye 2 (Suppl 1), S124–S139 (1988). https://doi.org/10.1038/eye.1988.139
Issue Date:
DOI: https://doi.org/10.1038/eye.1988.139
This article is cited by
-
Vascularised vitreoretinopathy: The role of growth factors
Eye (1996)
-
The extracellular matrix of reparative tissue in the vitreous: Fibronectin production in proliferative diabetic retinopathy membranes
Eye (1993)
-
Modulators and milieu in preretinal neovascularisation
Eye (1992)
-
Spontaneous relieving retinotomies in diabetic silicone filled eyes
Eye (1992)
-
Microsurgical management of neovascularisation secondary to posterior segment ischaemia
Eye (1991)